Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback